Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
theranostics
MedTech
GE HealthCare's PET agent Vizamyl expands reach in Alzheimer's
The imaging agent can be used to deliver quantitative assessments such as calculations of amyloid prevalence through FDA-authorized software.
Conor Hale
Jun 27, 2025 9:45am
GE HealthCare to put $138M into new Ireland contrast media plant
Jan 31, 2025 10:11am
Siemens Healthineers buys Novartis' EU radiodiagnostic network
Aug 26, 2024 11:30am
GE HealthCare sees theranostics gains, beating sales estimates
Feb 7, 2024 11:22am